Shares of Nanthealth LLC (NYSE:NH) shot up 4.1% during trading on Tuesday . The company traded as high as $12.94 and last traded at $12.82, with a volume of 61,150 shares traded. The stock had previously closed at $12.32.

A number of research firms have recently commented on NH. First Analysis began coverage on shares of Nanthealth in a research note on Monday, June 27th. They set an “overweight” rating and a $18.00 target price for the company. FBR & Co reissued a “buy” rating on shares of Nanthealth in a research note on Wednesday, August 10th. Canaccord Genuity began coverage on shares of Nanthealth in a research note on Monday, June 27th. They set a “buy” rating and a $17.00 target price for the company. Jefferies Group began coverage on shares of Nanthealth in a research note on Monday, June 27th. They set a “buy” rating for the company. Finally, Cowen and Company began coverage on shares of Nanthealth in a research note on Monday, June 27th. They set an “outperform” rating and a $19.00 target price for the company. Five analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and an average price target of $18.00.

The firm’s market cap is $1.55 billion. The firm has a 50-day moving average price of $11.59 and a 200-day moving average price of $12.39.

Nanthealth (NYSE:NH) last released its earnings results on Tuesday, August 9th. The company reported ($0.15) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.26. The firm earned $31.50 million during the quarter, compared to analyst estimates of $23.55 million. The business’s revenue was up 166.9% on a year-over-year basis. Equities research analysts anticipate that Nanthealth LLC will post ($0.59) EPS for the current fiscal year.

In related news, CEO Patrick Soon-Shiong purchased 357,143 shares of the business’s stock in a transaction dated Tuesday, June 7th. The stock was acquired at an average price of $14.00 per share, for a total transaction of $5,000,002.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, major shareholder Healthcare Solution Allscripts purchased 714,286 shares of the business’s stock in a transaction dated Tuesday, June 7th. The stock was bought at an average price of $14.00 per share, with a total value of $10,000,004.00. Following the acquisition, the insider now directly owns 15,000,000 shares in the company, valued at $210,000,000. The disclosure for this purchase can be found here.

Nant Health, LLC is an evidence-based, personalized healthcare company. The Company’s systems-based approach to personalized healthcare applies diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with real-time biometric signal and phenotypic data to track patient outcomes and deliver medicine.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.